TY  - JOUR
AU  - Epaillard, Nicolas
AU  - Parent, Pauline
AU  - Loriot, Yohann
AU  - Lavaud, Pernelle
AU  - Vera-Cea, E-B
AU  - Martinez-Chanza, Nieves
AU  - Rodriguez-Vida, Alejo
AU  - Dumont, Clement
AU  - Lozano, Rebeca
AU  - Llácer, Casilda
AU  - Ratta, Raffaele
AU  - Oudard, Stephane
AU  - Thibault, Constance
AU  - Auclin, Edouard
PY  - 2021
DO  - 10.3389/fonc.2021.671969
SN  - 2234-943X
UR  - https://hdl.handle.net/10668/25456
T2  - Frontiers in oncology
AB  - Less than one-third of bladder cancers are non-pure urothelial carcinoma [with variant histological (VH) or non-urothelial carcinoma (non-UC)] for which no treatment guidelines are available. We aim to evaluate the efficacy of systemic treatments in...
LA  - en
KW  - drug therapy
KW  - immunotherapy
KW  - mortality
KW  - urinary bladder neoplasms
KW  - variant histology
TI  - Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study.
TY  - research article
VL  - 11
ER  -